Document is current
Any future updates will be listed below
-
Authors
Nielsen, Berit Dalsgaard https://orcid.org/0000-0001-6291-157X
Hansen, Ib Tønder
Kramer, Stine
Haraldsen, Ate
Hjorthaug, Karin
Bogsrud, Trond Velde
Ejlersen, June Anita
Stolle, Lars Bjørn
Keller, Kresten Krarup
Therkildsen, Philip
Hauge, Ellen-Margrethe
Gormsen, Lars Christian
-
Funding
Funding for this research was provided by:
Sundhedsvidenskabelige Fakultet, Aarhus Universitet (16500395)
Gigtforeningen (DK) (R126-A3261)
Gigtforeningen (DK) (R161A5312)
Aase og Ejnar Danielsens Fond (10-001743)
Brødrene Hartmann Foundation (A29498)
Fonden til Lægevidenskabens Fremme (15-283)
- License Information
-
More Information
Article History
Received: 18 May 2018
Accepted: 18 July 2018
First Online: 31 July 2018
Compliance with ethical standards
:
: All procedures performed in the study were in accordance with the ethical standards of the National Committee on Health Research Ethics and with the 1964 Helsinki Declaration and its later amendments.The Central Denmark Region Committees on Health Research Ethics (reference number 1–10–72-246-16 and 1–10–72-60-14) and The Danish Data Protection Agency (reference number 1–16–02-380-14 and 1–16–02-481-16) approved the study.
: Ethical approval was given to assess 18F-FDG PET/CT of controls and to check prior and current diagnoses in their electronic medical record without informed consent from the patient. All GCA patients gave written, informed consent.
: Berit Dalsgaard Nielsen has received fees for speaking from Roche. Ellen-Margrethe Hauge has received fees for speaking from MSD, AbbVie, UCB and Sobi; and received research funding to Aarhus University Hospital from Roche and Novartis. Kresten Krarup Keller has received fees for speaking from Pfizer.
: The views expressed in the submitted article are the authors’ own and not an official position of the institution or funder.
